Advertisement

Index by Author

February 1994; 43 (2)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abdel-Halim, S M

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

  2. Ader, M

    • Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes February 1994 43:180-190; doi:10.2337/diabetes.43.2.180

  3. Anderson, E A

    • Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes February 1994 43:191-196; doi:10.2337/diabetes.43.2.191

  4. Assiz, R

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

B

  1. Baum, S T

    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

  2. Baxter, R C

    • Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes February 1994 43:232-239; doi:10.2337/diabetes.43.2.232

  3. Benzi, L

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

  4. Bergman, B

    • Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes February 1994 43:197-203; doi:10.2337/diabetes.43.2.197

  5. Bergman, R N

    • Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes February 1994 43:180-190; doi:10.2337/diabetes.43.2.180
    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

  6. Bernard, C

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

  7. Blackard, W G

    • Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM. Diabetes February 1994 43:256-262; doi:10.2337/diabetes.43.2.256

  8. Bogardus, C

    • Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes February 1994 43:191-196; doi:10.2337/diabetes.43.2.191

  9. Brelje, T C

    • Regulation of islet beta-cell proliferation by prolactin in rat islets. Diabetes February 1994 43:263-273; doi:10.2337/diabetes.43.2.263

  10. Bumbalo, L M

    • Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes February 1994 43:173-179; doi:10.2337/diabetes.43.2.173

  11. Butler, A E

    • Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes February 1994 43:329-336; doi:10.2337/diabetes.43.2.329

  12. Butler, P C

    • Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes February 1994 43:329-336; doi:10.2337/diabetes.43.2.329

C

  1. Cameron, K E

    • An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes February 1994 43:305-312; doi:10.2337/diabetes.43.2.305

  2. Caro, L H

    • Mutational analysis of the NH2-terminal glycosylation sites of the insulin receptor alpha-subunit. Diabetes February 1994 43:240-246; doi:10.2337/diabetes.43.2.240

  3. Caumo, A

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  4. Cecchetti, P

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

  5. Chen, C

    • Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes February 1994 43:173-179; doi:10.2337/diabetes.43.2.173

  6. Ciccarone, A

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

  7. Clore, J N

    • Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM. Diabetes February 1994 43:256-262; doi:10.2337/diabetes.43.2.256

  8. Cobelli, C

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  9. Cohen, D

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

  10. Cohen, O

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  11. Collier, E

    • Mutational analysis of the NH2-terminal glycosylation sites of the insulin receptor alpha-subunit. Diabetes February 1994 43:240-246; doi:10.2337/diabetes.43.2.240

D

  1. Di Cianni, G

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

E

  1. Eberle, A

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  2. Efendic, S

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

  3. Elson, D F

    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

F

  1. Flier, J S

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  2. Frank, R N

    • The aldose reductase controversy. Diabetes February 1994 43:169-172

  3. Froguel, P

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

G

  1. Gauguier, D

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

  2. Gorden, P

    • Mutational analysis of the NH2-terminal glycosylation sites of the insulin receptor alpha-subunit. Diabetes February 1994 43:240-246; doi:10.2337/diabetes.43.2.240

  3. Gougeon, R

    • Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes February 1994 43:318-328; doi:10.2337/diabetes.43.2.318

  4. Grigorescu, F

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  5. Grill, V

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

  6. Guenifi, A

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

H

  1. Haffner, S M

    • Insulin resistance, body fat distribution, and sex hormones in men. Diabetes February 1994 43:212-219; doi:10.2337/diabetes.43.2.212

  2. Hagino, H

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  3. Haskins, K

    • Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes February 1994 43:197-203; doi:10.2337/diabetes.43.2.197

  4. Homan, M

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  5. Hosomi, Y

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  6. Hozumi, T

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

I

  1. Ishida, Y

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

J

  1. Jensen, M

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  2. Johnson, K H

    • Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes February 1994 43:329-336; doi:10.2337/diabetes.43.2.329

K

  1. Karhapää, P

    • Insulin resistance, body fat distribution, and sex hormones in men. Diabetes February 1994 43:212-219; doi:10.2337/diabetes.43.2.212

  2. Katz, H

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  3. Kemnitz, J W

    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

  4. Kishimoto, M

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  5. Kong, Y

    • An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes February 1994 43:305-312; doi:10.2337/diabetes.43.2.305

L

  1. Laakso, M

    • Insulin resistance, body fat distribution, and sex hormones in men. Diabetes February 1994 43:212-219; doi:10.2337/diabetes.43.2.212

  2. Leahy, J L

    • Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats. Diabetes February 1994 43:173-179; doi:10.2337/diabetes.43.2.173

  3. Lewitt, M S

    • Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes February 1994 43:232-239; doi:10.2337/diabetes.43.2.232

  4. Luthman, H

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

M

  1. Marliss, E B

    • Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes February 1994 43:318-328; doi:10.2337/diabetes.43.2.318

  2. Marsac, C

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

  3. Matsuba, H

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  4. Meglasson, M D

    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

  5. Moller, D E

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  6. Moore, D M

    • Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes February 1994 43:180-190; doi:10.2337/diabetes.43.2.180

  7. Morrow, L A

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  8. Moses, A C

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  9. Mykkänen, L

    • Insulin resistance, body fat distribution, and sex hormones in men. Diabetes February 1994 43:212-219; doi:10.2337/diabetes.43.2.212

N

  1. Navalesi, R

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

  2. Nelson, I

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

O

  1. O'Brien, T D

    • Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes February 1994 43:329-336; doi:10.2337/diabetes.43.2.329

  2. Ohali, A

    • Mutational analysis of the NH2-terminal glycosylation sites of the insulin receptor alpha-subunit. Diabetes February 1994 43:240-246; doi:10.2337/diabetes.43.2.240

  3. Okada, Y

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  4. Ostenson, C G

    • Impact of diabetic inheritance on glucose tolerance and insulin secretion in spontaneously diabetic GK-Wistar rats. Diabetes February 1994 43:281-288; doi:10.2337/diabetes.43.2.281

P

  1. Parent, V

    • Higher maternal than paternal inheritance of diabetes in GK rats. Diabetes February 1994 43:220-224; doi:10.2337/diabetes.43.2.220

  2. Parsons, J A

    • Regulation of islet beta-cell proliferation by prolactin in rat islets. Diabetes February 1994 43:263-273; doi:10.2337/diabetes.43.2.263

  3. Pencharz, P B

    • Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes February 1994 43:318-328; doi:10.2337/diabetes.43.2.318

  4. Phyual, J L

    • Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes February 1994 43:232-239; doi:10.2337/diabetes.43.2.232

  5. Pihl, M

    • Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes February 1994 43:313-317; doi:10.2337/diabetes.43.2.313

  6. Pilo, A

    • Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes February 1994 43:297-304; doi:10.2337/diabetes.43.2.297

  7. Poulin, R A

    • Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes February 1994 43:180-190; doi:10.2337/diabetes.43.2.180

R

  1. Ravussin, E

    • Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes February 1994 43:191-196; doi:10.2337/diabetes.43.2.191

  2. Reichard, P

    • Mortality and treatment side-effects during long-term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study. Diabetes February 1994 43:313-317; doi:10.2337/diabetes.43.2.313

  3. Resnik, J L

    • An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes February 1994 43:305-312; doi:10.2337/diabetes.43.2.305

  4. Rizza, R

    • Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration. Diabetes February 1994 43:289-296; doi:10.2337/diabetes.43.2.289

  5. Robison, W G, Jr

    • Aldose reductase inhibition and retinopathy. Diabetes February 1994 43:337-339

  6. Roche, P C

    • Islet amyloid polypeptide in human insulinomas. Evidence for intracellular amyloidogenesis. Diabetes February 1994 43:329-336; doi:10.2337/diabetes.43.2.329

  7. Roecker, E B

    • Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes February 1994 43:204-211; doi:10.2337/diabetes.43.2.204

S

  1. Saunders, H

    • Regulation of insulin-like growth factor-binding protein-1 in rat serum. Diabetes February 1994 43:232-239; doi:10.2337/diabetes.43.2.232

  2. Sexton, W L

    • Skeletal muscle vascular transport capacity in diabetic rats. Diabetes February 1994 43:225-231; doi:10.2337/diabetes.43.2.225

  3. Shii, K

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  4. Sorenson, R L

    • Regulation of islet beta-cell proliferation by prolactin in rat islets. Diabetes February 1994 43:263-273; doi:10.2337/diabetes.43.2.263

  5. Spraul, M

    • Muscle sympathetic nerve activity in response to glucose ingestion. Impact of plasma insulin and body fat. Diabetes February 1994 43:191-196; doi:10.2337/diabetes.43.2.191

  6. Steil, G M

    • Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes February 1994 43:180-190; doi:10.2337/diabetes.43.2.180

W

  1. Webster, N J

    • An upstream element from the human insulin receptor gene promoter contains binding sites for C/EBP beta and NF-1. Diabetes February 1994 43:305-312; doi:10.2337/diabetes.43.2.305

Y

  1. Yamaguchi, Y

    • Prevalence of mutations in the insulin receptor gene in subjects with features of the type A syndrome of insulin resistance. Diabetes February 1994 43:247-255; doi:10.2337/diabetes.43.2.247

  2. Yokono, K

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

  3. Yoshida, M

    • Enzyme-linked immunosorbent assay method for human autophosphorylated insulin receptor. Applicability to insulin-resistant states. Diabetes February 1994 43:274-280; doi:10.2337/diabetes.43.2.274

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement